KPV.
A short anti-inflammatory tripeptide for gut, skin, and immune balance.
Pricing is shown after your free assessment, before you commit.
Free to start. No card required.
Reviewed by Lumora clinical team (Licensed provider network)Mixed evidenceSource: Client-approved product catalog; provider review required
Evidence, regulatory status, and fit vary by medication, formulation, route, and individual history.
Is this for you?
This is for you if
- Patients with gut inflammation, IBS-type symptoms, or food sensitivities
- Patients with inflammatory skin conditions (eczema, acne, rosacea)
- Patients wanting immune-calming support without immunosuppression
- Patients who are sensitive to stronger peptides
This isn't for you if
Generally well tolerated. Not appropriate during pregnancy or with active autoimmune flares without specialist clearance.
KPV
KPV is a short anti-inflammatory peptide derived from alpha-melanocyte-stimulating hormone (α-MSH). It calms inflammation locally and systemically without broadly suppressing the immune system — useful in protocols for gut and skin conditions.
Mechanism and fit.
KPV downregulates several inflammatory pathways involved in gut and skin conditions, supporting immune balance rather than suppression. It is particularly useful in conditions such as IBS-type symptoms, food sensitivities, eczema, acne, and rosacea.
Who this is typically for.
- Patients with gut inflammation, IBS-type symptoms, or food sensitivities
- Patients with inflammatory skin conditions (eczema, acne, rosacea)
- Patients wanting immune-calming support without immunosuppression
- Patients who are sensitive to stronger peptides
What patients
most often ask.
How is KPV different from immunosuppressants?
KPV calms inflammation without broadly suppressing the immune system, which makes it useful in chronic inflammatory and gut conditions without the broader downsides of immunosuppressive medications.
Who this is typically for.
These are common fit patterns from the approved catalog. Your provider determines whether treatment is appropriate.
- <ul><li>Patients with gut inflammation, IBS-type symptoms, or food sensitivities</li><li>Patients with inflammatory skin conditions (eczema, acne, rosacea)</li><li>Patients wanting immune-calming support without immunosuppression</li><li>Patients who are sensitive to stronger peptides</li></ul>
How this option
is evaluated.
The plan is provider-determined after reviewing your assessment and safety factors.
- DosingDaily, oral, sublingual, or injectable depending on protocol.
- Typical duration6–8 weeks per cycle.
- Safety and eligibilityYour provider reviews contraindications, medication interactions, goals, and safety factors before prescribing.
- A licensed provider reviews your assessment before any treatment is recommended.
- You see full pricing - visit fees, medication, labs, follow-up - before you commit.
- Your plan can be adjusted, paused, or stopped based on response and safety. Your clinician is reachable - not a chatbot.
- Compounded medications are not FDA-approved and are dispensed only when prescribed by a licensed provider.
Start with
provider review.
If you are considering KPV, the first step is a free assessment. A provider determines whether it fits your goals and medical history.
A provider determines whether treatment is clinically appropriate.